Beruflich Dokumente
Kultur Dokumente
DAFTAR PUSTAKA
Aleskandarany MA, Rakha EA, Macmillan RD, Powe DG, Ellis IO, Green AR,
2011, MIB1/Ki-67 labelling index can classify grade 2 breast cancer into
two clinically distinct subgroups (Diunduh tanggal 15 Oktober 2014).
American Cancer Society, 2013, Breast Cancer Facts & Figures, Atlanta, Georgia
(Diunduh tanggal 14 Oktober 2014).
American Joint Comittee on Cancer, 2010, Breast Cancer Staging (Diunduh
tanggal 14 Oktober 2014).
Ander Urruticoechea, Ian E. Smith, Mitch Dowsett, 2005, Proliferation Marker
Ki-67 in Early Breast Cancer (Diunduh tanggal 15 Oktober 2014).
Cattoretti G, Becker MH, Key G, Duchrow M, Schlter C, Galle J, Gerdes J,1992,
Monoclonal antibodies against recombinant parts of the Ki-67 antigen
(MIB 1 and MIB 3) detect proliferating cells in microwave-processed
formalin-fixed paraffin sections (Diunduh tanggal 15 Oktober 2014).
E. C. Inwald, M. Klinkhammer-Schalke, F. Hofstdter, 2013, Ki-67 is a
prognostic parameter in breast cancer patients: results of a large
population-based cohort of a cancer registry
Gerdes J, Scholzen T, 1980, The Ki-67 protein: from the known and the unknown
(Diunduh tanggal 14 Oktober 2014).
Haroon S, Hashmi A A, Khurshid A, Kanpurwala MA, Mujtuba S, Malik B, Faridi
N, 2013, Ki67 index in breast cancer: correlation with other prognostic
markers and potential in pakistani patients (Diunduh tanggal 15 Oktober
2014).
Inwald EC, Klinkhammer-Schalke M, Hofstdter F, et al,. 2013, Ki-67 is a
prognostic parameter in breast cancer patients: results of a large
population-based cohort of a cancer registry (Diunduh tanggal 15 Oktober
2014).
National Breast Cancer Foundation, 2014, http://www.nationalbreastcancer.
org/causes-of-breast-cancer (Diunduh tanggal 14 Oktober 2014)
S Fasanella, E Leonard, C Cantaloni, et al,. 2011, Proliferative activity in human
breast cancer: Ki-67 automated evaluation and the influence of different Ki67 equivalent antibodies, (Diunduh tanggal 14 Oktober 2014).
51